MLH1 and rectal cancer: For MLH1, the authors focused on an intronic variant, rs4647269 (c.791-1406C>T), and observed that its carriers exhibited a decreased risk of rectal cancer (OR = 0.71, 95% CI = 0.51–0.9, p = 0.04) [54].